SEARCH

SEARCH BY CITATION

References

  • 1
    . Willkens RF, Watson MA: Methotrexate: a perspective of its use in the treatment of rheumatic diseases. J Lab Clin Med 100: 314321, 1982
  • 2
    . Steinsson K, Weinstein A, Korn J, Abeles M: Low dose methotrexate in rheumatoid arthritis. J Rheumatol 9: 860866, 1982
  • 3
    . Weinstein A, Marlowe S, Korn J, Farouhar F: Lowdose methotrexate treatment in rheumatoid arthritis. Am J Med 79: 331337, 1985
  • 4
    . Wilke WS, Calabrese LH, Scherbel AL: Methotrexate in the treatment of rheumatoid arthritis: pilot study. Cleve Clin Q 47: 305309, 1980
  • 5
    . Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of lowdose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818822, 1985
  • 6
    . Williams HJ, Willkens RF, Samuelson CO Jr, Alarcón GS. Guitadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985
  • 7
    . Thompson RN. Watts C, Edelman J, Esdaile J, Russell AS: A controlled two centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 11: 760763, 1984
  • 8
    . Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489496, 1985
  • 9
    . Weinblatt ME. Trentham DE, Fraser PA, Holdsworth DE. Falchuk KR. Weissman BN, Coblyn JS: Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 167175, 1988
  • 10
    . Kremer JM, Lee JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty-three months. Arthritis Rheum 31: 577584, 1988
  • 11
    . Nordstrom DM, West SG, Andersen PA, Sharp JT: Pulse methotrexate therapy in rheumatoid arthritis: a controlled prospective roentgenographic study. Ann Intern Med 107: 797801, 1987
  • 12
    . Hamdy H. McKendry RJR, Mierins E, Liver JA: Lowdose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty-four-week controlled clinical trial. Arthritis Rheum 30: 361368, 1987
  • 13
    . Bell M, Chang C-H, Keystone EC, Urowitz MB, Gladman D. Ching C-F: A double-blind randomized controlled trial of azathioprine and methotrexate in the treatment of rheumatoid arthritis (abstract). Arthritis Rheum 31 (suppl 4): S114, 1988
  • 14
    . Wenger ME, Alexander S, Bland JH, Blechman WJ: Auranofin versus placebo in the treatment of rheumatoid arthritis. Am J Med 75: 123127, 1983
  • 15
    . Ward JR, Williams HJ, Egger MJ, Reading JC, Boyce E, Altz-Smith M. Samuelson CO Jr, Willkens RF, Solsky MA. Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M, Kaplan SB, Klippel J: Comparison of auranofin, gold sedium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 26: 13031315, 1983
  • 16
    . Katz WA, Alexander S, Bland JH, Blechman W, Bluhm BG, Bonebrake RA, Falbo A, Greenwald RA, Hartman S, Hobbs T, Indenbaum S, Lergier JE, Lanier BG, Lightfoot RW Jr, Phelps P, Sheon RP, Torretti D, Wenger ME, Wilske K: The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. J Rheumatol [Suppl] 9: 173178, 1982
  • 17
    . Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, Trang L: Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, doubleblind, placebo controlled study. J Rheumatol 15: 17471754, 1988
  • 18
    . Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL: Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med 81: 565578, 1986
  • 19
    . Menard HA, Beaudet F, Davis P, Harth M, Percy JS, Russell AS, Thompson JM: Gold therapy in rheumatoid arthritis: interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. J Rheumatol [Suppl] 9: 179183, 1982
  • 20
    . Manthorpe R, Horbov S, Sylvest J, Vinterberg H: Auranofin versus penicillamine in rheumatoid arthritis: one-year results from a prospective clinical investigation. Scand J Rheumatol 15: 1322, 1986
  • 21
    . Hochberg MC: Auranofin or D-penicillamine in the treatment of rheumatoid arthritis. Ann Intern Med 105: 528535, 1986
  • 22
    . Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 23
    . Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 24
    . Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP: Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26: 13461353, 1983
  • 25
    . Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS: A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol 15: 753756, 1988
  • 26
    . Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJR: Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26-week trial. J Rheumatol 16: 302306, 1989
  • 27
    . Weinstein A, Bujak D, Marlowe S, Parke A, Zabrockie F, Peterson M: Methotrexate or gold in early rheumatoid arthritis: a double blind study (abstract). Arthritis Rheum 30 (suppl 4): S94, 1987
  • 28
    . Rau R, Herborn G, Karger T, Menninger H, Elhardt D: A blinded randomised trial of methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis (abstract). Arthritis Rheum 32 (suppl 4): S43, 1989
  • 29
    . Blodgett RC, Heuer MA, Pietrusko RG: Auranofin: a unique oral chrysotherapeutic agent. Semin Arthritis Rheum 13: 255273, 1984
  • 30
    . Heuer MA, Pietrusko RG, Morris RW, Scheffler BJ: An analysis of worldwide safety experience with auranofin. J Rheumatol 12: 695699, 1985